{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T16:19:37Z","timestamp":1793377177909,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2005,5,1]],"date-time":"2005-05-01T00:00:00Z","timestamp":1114905600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,24]],"date-time":"2019-12-24T00:00:00Z","timestamp":1577145600000},"content-version":"vor","delay-in-days":5350,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Annals of Oncology"],"published-print":{"date-parts":[[2005,5]]},"DOI":"10.1093\/annonc\/mdi156","type":"journal-article","created":{"date-parts":[[2005,4,8]],"date-time":"2005-04-08T00:14:03Z","timestamp":1112919243000},"page":"825-833","source":"Crossref","is-referenced-by-count":167,"title":["An implantable drug delivery system (IDDS) for refractory cancer pain provides sustained pain control, less drug-related toxicity, and possibly better survival compared with comprehensive medical management (CMM)"],"prefix":"10.1016","volume":"16","author":[{"given":"T.J.","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.J.","family":"Coyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P.S.","family":"Staats","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T.","family":"Deer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L.J.","family":"Stearns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.L.","family":"Rauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.L.","family":"Boortz-Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Buchser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E.","family":"Catal\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D.A.","family":"Bryce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Cousins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G.E.","family":"Pool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1093\/annonc\/mdi156_bb0010","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0304-3959(01)00324-4","article-title":"Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence","volume":"93","author":"Meuser","year":"2001","journal-title":"severity and etiology. Pain"},{"key":"10.1093\/annonc\/mdi156_bb0015","doi-asserted-by":"crossref","first-page":"4040","DOI":"10.1200\/JCO.2002.02.118","article-title":"Randomized clinical trial of an implantable drug delivery system compared with comprehensive medical management for refractory cancer pain: impact on pain, drug-related toxicity","volume":"20","author":"Smith","year":"2002","journal-title":"and survival. J Clin Oncol"},{"key":"10.1093\/annonc\/mdi156_bb0020","series-title":"Agency for Health Care Policy and Research (AHCPR publication","article-title":"Management of Cancer Pain. Clinical Practice Guideline No. 9","volume":"94\u20130592","author":"Jacox","year":"1994"},{"key":"10.1093\/annonc\/mdi156_bb0025","doi-asserted-by":"crossref","first-page":"185","DOI":"10.3816\/SCT.2004.n.011","article-title":"What is the evidence of the implantable drug delivery systems for refractory cancer pain?","volume":"1","author":"Smith","year":"2004","journal-title":"Support Cancer Ther"},{"key":"10.1093\/annonc\/mdi156_bb0030","first-page":"531","article-title":"The implantable drug delivery trial group preliminary estimates of the cost effectiveness (CE) ratio of implantable drug delivery systems (IDDS) compared to comprehensive medical management (CMM) in patients with refractory cancer pain","volume":"22","author":"Hillner","year":"2003","journal-title":"Proc Am Soc Clin Oncol"},{"key":"10.1093\/annonc\/mdi156_bb0035","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1200\/JCO.1999.17.1.361","article-title":"Implementing guidelines for cancer pain management: results of a randomized controlled clinical trial","volume":"17","author":"DuPen","year":"1999","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi156_bb0040","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1056\/NEJM199403033300902","article-title":"Pain and its treatment in outpatients with metastatic cancer","volume":"330","author":"Cleeland","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdi156_bb0045","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0885-3924(96)00042-5","article-title":"Prevalence of symptoms among patients with advanced cancer: an international collaborative study","volume":"12","author":"Vainio","year":"1996","journal-title":"Symptom Prevalence Group. J Pain Symptom Manage"},{"key":"10.1093\/annonc\/mdi156_bb0050","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1200\/JCO.2001.19.23.4275","article-title":"Lack of adherence with the analgesic regimen: a significant barrier to effective cancer pain management","volume":"19","author":"Miaskowski","year":"2001","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi156_bb0055","doi-asserted-by":"crossref","first-page":"1604","DOI":"10.1056\/NEJM198506203122504","article-title":"The Will Rogers phenomenon. Stage migration and new diagnostic techniques as a source of misleading statistics for survival in cancer","volume":"312","author":"Feinstein","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1093\/annonc\/mdi156_bb0060","first-page":"43","article-title":"Stress and morphine affect survival of rats challenged with a mammary ascites tumor (MAT 13762B)","volume":"3","author":"Lewis","year":"1983","journal-title":"Nat Immune Cell Growth Regulation"},{"key":"10.1093\/annonc\/mdi156_bb0065","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0006-8993(86)91149-2","article-title":"Effects of footshock stress and morphine on natural killer lymphocytes in rats: studies of tolerance and cross tolerance","volume":"372","author":"Shavit","year":"1986","journal-title":"Brain Res"},{"key":"10.1093\/annonc\/mdi156_bb0070","first-page":"3","volume":"44","author":"Pain","year":"1991","journal-title":"Liebeskind JC. Pain can kill."},{"key":"10.1093\/annonc\/mdi156_bb0075","first-page":"4491","article-title":"Morphine stimulates angiogenesis by activating proangiogenic and survival-promoting signaling and promotes breast tumor growth","volume":"62","author":"Gupta","year":"2002","journal-title":"Cancer Res"},{"key":"10.1093\/annonc\/mdi156_bb0080","article-title":"Palliative care project: bridging active treatment and hospice for terminal cancer","author":"Finn","year":"1452","journal-title":"Proc ASCO2002"},{"key":"10.1093\/annonc\/mdi156_bb0085","first-page":"447","article-title":"Chemical splanchnicectomy in patients with unresectable pancreatic cancer","volume":"217","author":"Lillemoe","year":"1993","journal-title":"A prospective randomized trial. Ann Surg"},{"key":"10.1093\/annonc\/mdi156_bb0090","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1001\/jama.291.9.1092","article-title":"The effect of neurolytic celiac plexus block on pain relief, quality of life, and survival in patients with unresectable pancreatic cancer: a prospective, double blinded, randomized clinical trial","volume":"291","author":"Wong","year":"2004","journal-title":"JAMA"},{"key":"10.1093\/annonc\/mdi156_bb0095","first-page":"2486","article-title":"Effects of epoetin alfa on hematologic parameters and quality of life in cancer patients receiving non-platinum chemotherapy: results of a randomized, double-blind placebo-controlled trial","volume":"20","author":"Littlewood","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi156_bb0100","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1093\/jnci\/94.16.1211","article-title":"Double-blind, placebo-controlled, randomized phase III trial of darbepoetin alfa in lung cancer patients receiving chemotherapy","volume":"94","author":"Vansteenkiste","year":"2002","journal-title":"J Nat Cancer Inst"},{"key":"10.1093\/annonc\/mdi156_bb0105","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/0885-3924(91)90028-3","article-title":"Cost analysis of two implantable narcotic delivery system","volume":"6","author":"Bedder","year":"1991","journal-title":"J Pain Symptom Manage"},{"key":"10.1093\/annonc\/mdi156_bb0110","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1200\/JCO.2000.18.1.72","article-title":"Pamidronate in prevention of bone complications in metastatic breast cancer: a cost-effectiveness analysis","volume":"18","author":"Hillner","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1093\/annonc\/mdi156_bb0115","doi-asserted-by":"crossref","first-page":"3302","DOI":"10.1200\/JCO.2000.18.18.3302","article-title":"Systematic overview of cost-utility assessments in oncology","volume":"18","author":"Earle","year":"2000","journal-title":"J Clin Oncol"}],"container-title":["Annals of Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419505142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0923753419505142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/academic.oup.com\/annonc\/article-pdf\/16\/5\/825\/352098\/mdi156.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,20]],"date-time":"2020-02-20T18:05:49Z","timestamp":1582221949000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0923753419505142"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,5]]}},"alternative-id":["S0923753419505142"],"URL":"https:\/\/doi.org\/10.1093\/annonc\/mdi156","relation":{},"ISSN":["0923-7534"],"issn-type":[{"value":"0923-7534","type":"print"}],"subject":[],"published":{"date-parts":[[2005,5]]}}}